Cerebras CTO Lie Sean Reports Multiple Stock Transactions
Lie Sean, CTO of Cerebras Systems, reported several stock transactions, including acquisitions and sales of Class A Common Stock, in recent SEC filings.
CEO Daniel E. Brown Acquires Over 58,000 Shares of Expand Energy
Expand Energy's CEO Daniel E. Brown acquires over 58,000 shares and performance units, signaling confidence in the company's future.
Docler Holding Amends Stake in Playboy, Inc. to 12.8%
Docler Holding S.a r.l. updates its stake in Playboy, Inc. to 12.8%, following a recent share issuance and backstop agreement amendment.
JDH Capital I, L.P. Acquires 16.7% Stake in Smith & Wesson
JDH Capital I, L.P. has acquired 16.7% of Smith & Wesson Brands, Inc. through a merger, marking a significant move in the ordnance and accessories industry.
Bluerock Private Real Estate Fund Director Acquires Shares
Kamfar Ramin, a director at Bluerock Private Real Estate Fund, acquires over 100,000 shares, signaling confidence in the company's future.
Saba Capital Management increases stake in BNY Mellon fund
Saba Capital Management, L.P. boosts its holdings in BNY Mellon Strategic Municipal Bond Fund, signaling strategic moves in the asset management sector.
CRISPR's Kasinger Acquires 18,000 Stock Options, 9,000 RSUs
James R. Kasinger of CRISPR Therapeutics acquires significant stock options and restricted stock units, reflecting trends in executive compensation in the biotech sector.
Bradley & Daytona Railway files amendment amid Power REIT dispute
Bradley & Daytona Railway & Land Co. LLC files an amendment to Schedule 13D, initiating litigation against Power REIT over governance issues.
Fundrise Innovation Fund II files amended registration statement
Fundrise Innovation Fund II, LLC has filed an amended registration statement to enhance its investment offerings, targeting retail investors in innovation sectors.
Karyopharm Therapeutics sees new investment from Integrated Core Strategies
Karyopharm Therapeutics reports new investment from Integrated Core Strategies, reflecting continued interest in the pharmaceutical sector.
Tempus AI reports significant stock ownership changes
Tempus AI, Inc. reveals updates on stock ownership by Bradley A. Keywell and related entities, impacting the company's direction and industry dynamics.
Sanchez Reports Multiple Stock Transactions at Ryder System
Robert E. Sanchez, Executive Chair of Ryder System Inc., reports significant stock transactions, acquiring 77,407 shares at $74.72 each.
Versant Vantage II GP, L.P. Acquires Major Stake in Lycia
Versant Vantage II GP, L.P. has acquired over 25 million shares of Lycia Therapeutics, Inc., enhancing its influence in the biological products sector.
Neal J. Keating Acquires 3,000 Shares of Hexcel Corp
Neal J. Keating reports acquisition of 3,000 shares in Hexcel Corp, emphasizing commitment to the aerospace and defense materials industry.
First Breach terminates joint venture with ideaForge Technology
First Breach, Inc. ends its joint venture with ideaForge, saving a planned $25 million investment and refocusing on its own UAV manufacturing.
Star Equity Holdings announces acquisition of PD Machine, LLC
Star Equity Holdings, Inc. has acquired PD Machine, LLC, expanding its capabilities in the help supply services sector, a move that could reshape industry dynamics.
TechPrecision Corp extends credit line maturity to November 2026
TechPrecision Corp has extended the maturity date of its revolving credit line to November 30, 2026, as part of its financial management strategy.
Philotimo Fund Discloses 3.4% Stake in Apyx Medical Corp
Philotimo Fund, LP reveals a 3.4% ownership in Apyx Medical Corp, potentially impacting the surgical and medical instruments market.
Curaleaf Responds to Alberta Securities Commission Ruling
Curaleaf Holdings responds to Alberta Securities Commission's decision on Aurora Cannabis's at-the-market program, raising key questions about share dilution.
Curaleaf responds to Alberta Securities Commission ruling
Curaleaf Holdings responds to Alberta Securities Commission's ruling on Aurora Cannabis, emphasizing its premium offer and ongoing interest in a merger.